74.14

0.80% 0.64

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $74.14, with a volume of 345.32K. It is up +0.80% in the last 24 hours and down -5.82% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$73.50

Open:

$74.31

24h Volume:

345.32K

Relative Volume:

0.18

Market Cap:

$2.47B

Revenue:

$401.09M

Net Income/Loss:

$32.64M

P/E Ratio:

78.87

EPS:

0.94

Net Cash Flow:

$-120.51M

1W Performance:

+9.68%

1M Performance:

-5.82%

6M Performance:

-49.20%

1Y Performance:

-15.96%

1-Day Range:

$72.92

$75.20

1-Week Range:

$64.30

$76.36

52-Week Range:

$55.00

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1186)

Industry

Medical Devices (159)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

584

Twitter

@transmedics

Next Earnings Date

2024-10-28

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	74.06	2.47B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	129.00	222.39B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	105.44	154.78B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	394.11	150.99B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	90.33	116.46B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.42	41.87B	6.60B	4.16B	490.10M	6.93

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

04:10 AM

Clear Creek Financial Management LLC Takes $352,000 Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

04:10 AM

02:05 AM

Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - Victoria Advocate

02:05 AM

01:14 AM

Tempus Wealth Planning LLC Takes $346,000 Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

01:14 AM

Feb 06, 2025

What is Transmedics Group Inc (TMDX) Stock Return on Shareholders’ Capital? - SETE News

Feb 06, 2025